--TransCode Therapeutics, Inc., the RNA Oncology Company TM committed to more effectively treating cancer using RNA therapeutics, announced today that it has received Orphan Drug Designation from ...

Neuralink, Elon Musk's brain-computer technology firm, self-certified with the Small Business Administration in Washington as ...

Ramsey, NJ, July 06, 2023 (GLOBE NEWSWIRE) -- Konica Minolta Business Solutions U.S.A., Inc. (Konica Minolta), an award-winning content services solutions provider, today announced it has achieved ...

KLTO‑202 is an experimental gene therapy that would deliver the instructions for a protein that may reduce inflammation and ...

A "cheat sheet" to track residents' code status has become a source of controversy in the case of a Minnesota man who died without being given CPR, according to local news sources.

TransCode Therapeutics Announces Orphan Drug Designation Status for TTX-MC138 for Treatment of Pancreatic Cancer. TransCode Therapeutics, Inc. Tue, Feb 28, 2023, 7:00 AM 6 min read.